Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (23 ops.)
Latest filing published 31 Jan 2018 for REPROS THERAPEUTICS INC., €15k.
Insider track record
Disclosed buys
9
Disclosed sells
23
Signal history
Closed purchases
Market purchases
9
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Patrick Fourteau: trading record in brief
Filings by Patrick Fourteau span 3 companies, the busiest being First Horizon Pharmaceutical Corp, Insys Therapeutics, Inc. and Repros Therapeutics Inc. Between 24 January 2006 and 31 January 2018, the trades on record add up to 46 filings.
Both buying and selling appear: 9 purchases worth €618k, against 23 sales worth €15.3M. Netting one side against the other leaves €14.7M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants and 8 option exercises.
The median purchase comes to €49k.
Most recently, on 31 January 2018, the filings show a transaction worth €6,588 in Repros Therapeutics Inc. The clock since the last published purchase (15 May 2014) now reads 4,544 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Patrick Fourteau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations45 total
27,779 shares@ US$0.6769.5% of flowCommon StockSEC:0001144204-18-004787:1
12,221 shares@ US$0.6730.5% of flowCommon StockSEC:0001144204-18-004787:0
10,000 shares@ US$1.622.5% of flowCommon StockSEC:0001209191-17-047756:0
10,000 shares@ US$3.635.9% of flowCommon StockSEC:0001209191-17-035824:0
40,000 sharesCommon StockSEC:0001144204-17-009364:0
15,000 shares@ US$18.4645.7% of flowCommon StockSEC:0001209191-16-136823:0
15,000 shares@ US$18.2245.9% of flowCommon StockSEC:0001209191-16-106146:0
30,000 shares@ US$26.48Common StockSEC:0001209191-15-080009:0
4,784 shares@ US$60.00Common StockSEC:0001209191-15-047219:0
1,311 shares@ US$60.14Common StockSEC:0001209191-15-047219:1
2,969 shares@ US$60.00Common StockSEC:0001209191-15-044996:0
6,095 shares@ US$60.00Common StockSEC:0001209191-15-044996:1
10,000 shares@ US$59.94Common StockSEC:0001209191-15-025518:0
25,000 shares@ US$39.11Common StockSEC:0001209191-14-070401:0
4,500 shares@ US$22.95Common StockSEC:0001209191-14-034375:0
Canonical exit: 13 Aug 2014 (T+90)
3,000 shares@ US$22.50Common StockSEC:0001209191-14-034375:1
Canonical exit: 13 Aug 2014 (T+90)
5,000 shares@ US$23.77Common StockSEC:0001209191-13-040910:0
Canonical exit: 12 Nov 2013 (T+90)
5,000 shares@ US$10.90Common StockSEC:0001209191-13-026315:0
Canonical exit: 12 Aug 2013 (T+90)
2,800 shares@ US$10.75Common StockSEC:0001209191-13-025938:0
Canonical exit: 7 Aug 2013 (T+90)
2,000 shares@ US$11.10Common StockSEC:0001209191-13-025938:1
Canonical exit: 11 Aug 2013 (T+90)
200 shares@ US$10.40Common StockSEC:0001209191-13-025888:0
Canonical exit: 6 Aug 2013 (T+90)
37,500 shares@ US$8.00Common StockSEC:0001209191-13-024866:0
Canonical exit: 5 Aug 2013 (T+90)
12,500 shares@ US$9.45Common StockSEC:0001209191-13-024866:1
Canonical exit: 5 Aug 2013 (T+90)
100,000 sharesCommonSEC:0001104659-08-053653:0
100,000 shares@ US$21.37CommonSEC:0001104659-08-053653:1
25 of 45 declarations
